Perritt Capital Management Inc Pfizer Inc Transaction History

Perritt Capital Management Inc

$173 Million
Q2 2024

A detailed history of Perritt Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Perritt Capital Management Inc holds 19,179 shares of PFE stock, worth $547,176. This represents 0.31% of its overall portfolio holdings.

Number of Shares

19,179

Previous 16,283 17.79%

Holding current value

$547,176

Previous $451,000 18.85%

% of portfolio

0.31%

Previous 0.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $73,152 - $85,721	2,896 Added 17.79%	19,179 $536,000
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $33,242 - $38,173	1,284 Added 8.56%	16,283 $451,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $118,159 - $153,476	-4,522 Reduced 23.16%	14,999 $431,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $50,813 - $66,151	-1,290 Reduced 6.2%	19,521 $796,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $43,754 - $57,116	-1,048 Reduced 4.79%	20,811 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $16,847 - $20,566	-385 Reduced 1.73%	21,859 $957,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $13,959 - $16,551	-300 Reduced 1.33%	22,244 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $2,479 - $3,675	60 Added 0.27%	22,544 $1.33 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $7,850 - $10,084	-200 Reduced 0.88%	22,484 $967,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $66,648 - $75,502	1,856 Added 8.91%	22,684 $888,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $51,407 - $57,976	1,535 Added 7.96%	20,828 $755,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $66,538 - $84,609	1,988 Added 11.49%	19,293 $710,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $9,398 - $11,026	296 Added 1.74%	17,305 $635,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $10,301 - $12,496	342 Added 2.05%	17,009 $556,000
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $3,983 - $4,520	-121 Reduced 0.72%	16,667 $653,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $1,429 - $1,853	-44 Reduced 0.26%	16,788 $603,000
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $1,627 - $1,826	44 Added 0.26%	16,832 $715,000
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $1,627 - $1,826	-44 Reduced 0.26%	16,788 $727,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1,755 - $2,036	-55 Reduced 0.33%	16,832 $598,000
Q4 2017 Jan 25, 2018	BUY	$33.26 - $35.29 $3,459 - $3,670	104 Added 0.62%	16,887 $612,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $520,273 - $573,139	16,783	16,783 $599,000

Others Institutions Holding PFE

# of Institutions

3,231

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Pfizer Inc Transaction History